Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 7:59 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 15,116,496 9.900% | 9,872,873 (+188.28%) | View |
| 2024-11-14 5:47 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II L.P. | 11,516,667 9.990% | 2,477,823 (+27.41%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 10,497,990 9.300% | 4,325,904 (+70.09%) | View |
| 2024-11-14 3:52 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -5,481,034 (Position Closed) | View |
| 2024-11-14 12:24 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Kynam Capital Management LP | 9,239,731 8.360% | 3,384,965 (+57.82%) | View |
| 2024-11-07 09:24 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | FMR LLC | 13,208,972 12.068% | 4,889,561 (+58.77%) | View |
| 2024-11-07 09:12 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | FMR LLC | 8,319,411 7.601% | 3,016,557 (+56.89%) | View |
| 2024-06-13 06:06 am Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 11,330,141 9.900% | 1,343,585 (+13.45%) | View |
| 2024-04-01 6:30 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 9,986,556 9.900% | -31,519 (-0.31%) | View |
| 2024-03-27 4:37 pm Sale | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 10,018,075 9.900% | -13,061,066 (-56.59%) | View |
| 2024-02-16 6:55 pm Purchase | 13D | COGENT BIOSCIENCES INC COGT | Fairmount Funds Management LLC | 23,079,141 18.890% | 3,116,577 (+15.61%) | View |
| 2024-02-14 8:33 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II L.P. | 9,038,844 9.990% | 1,729,716 (+23.67%) | View |
| 2024-02-14 5:01 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,999,481 (Position Closed) | View |
| 2024-02-14 4:11 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Point72 Asset Management L.P. | 5,243,623 6.100% | 1,680,721 (+47.17%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 6,172,086 7.100% | 1,246,086 (+25.30%) | View |
| 2024-02-14 12:51 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Kynam Capital Management LP | 5,854,766 6.800% | 5,854,766 (New Position) | View |
| 2024-02-13 5:02 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | VANGUARD GROUP INC | 4,534,655 5.270% | 4,534,655 (New Position) | View |
| 2024-02-09 4:22 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 5,631,042 6.500% | 2,000,000 (+55.08%) | View |
| 2024-02-09 08:50 am Purchase | 13G | COGENT BIOSCIENCES INC COGT | FMR LLC | 5,302,854 6.157% | 5,302,854 (New Position) | View |
| 2024-02-05 4:43 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | SUVRETTA CAPITAL MANAGEMENT LLC | 5,481,034 6.400% | 5,481,034 (New Position) | View |